Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × tomivosertib × Clear all

NCT03318562 2019-07-18

A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC

Phase 2 Terminated

BreastGastrointestinal

Carcinoma, Hepatocellular, Triple Negative Breast Neoplasms